Park Ha Biological Technology Co., Ltd.
For the period ended Jul 6, 2026. Filed Jul 6, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jul 6, 2026 · Filed Jul 6, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · CLASS B VARIATION
CLASS B VARIATION
The Board has approved, subject to the separate approval of the holders of Class B Ordinary Shares and Class A Ordinary Shares in accordance with Article 6 of the Company’s Amended and Restated Memorandum and Articles of Association, the variation of the voting rights attaching to the Class B Ordinary Shares such that each Class B Ordinary Share will carry one hundred (100) votes instead of twenty (20) votes.
IT IS RESOLVED THAT, by way of a special resolution, subject to the approval of the holders of Class B Ordinary Shares by way of written consent in accordance with Article 6 of the Company’s existing amended and restated memorandum and articles of association, the voting rights attaching to each Class B Ordinary Share be varied such that each Class B Ordinary Share shall carry one hundred (100) votes instead of twenty (20) votes, and any Authorised Person be and is hereby authorised for and on behalf of the Company to do all such acts and things as such Authorised Person considers necessary or desirable to implement, carry out and give effect to the foregoing (the “Class A Meeting Proposal No. 1”).
At the Class A Meeting, the Class A Meeting Proposal No. 1will be approved if the affirmative vote of not less than two-thirds of the votes cast by holders of Class A Ordinary Shares entitled to vote at the Class A Meeting vote “FOR” the proposal.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.